Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs (Q37615893)

21 August 2017

1 reference

title

Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs (English)

1 reference

21 August 2017

0 references

Mayte Coiras

1 reference

21 August 2017

María Rosa López-Huertas

series ordinal

1 reference

21 August 2017

Mayte Pérez-Olmeda

series ordinal

1 reference

21 August 2017

José Alcamí

series ordinal

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

Nature Reviews Microbiology

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

798-812

1 reference

IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Persistence of infectious HIV on follicular dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Histone deacetylase 1 can repress transcription by binding to Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Maraviroc for previously treated patients with R5 HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Twenty years of therapy for HIV-1 infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

The regulation of HIV-1 gene expression: the emerging role of chromatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Beginning to understand microRNA function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Experimental approaches to the study of HIV-1 latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

The multifactorial nature of HIV-1 latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Nuclear import of the pre-integration complex (PIC): the Achilles heel of HIV?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Visualization of the intracellular behavior of HIV in living cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

An essential role for LEDGF/p75 in HIV integration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Wild-type levels of human immunodeficiency virus type 1 infectivity in the absence of cellular emerin protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

31 March 2020

THE HIV-1 REV PROTEIN

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

The structural biology of HIV assembly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Active nuclear import of human immunodeficiency virus type 1 preintegration complexes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Human macrophages support persistent transcription from unintegrated HIV-1 DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Recombination: Multiply infected spleen cells in HIV patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Generation of HIV latency during thymopoiesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Regulation of HIV-1 latency by T-cell activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV preferentially infects HIV-specific CD4+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV disease: fallout from a mucosal catastrophe?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Highly purified CD25- resting T cells cannot be infected de novo with HIV-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Macrophages archive HIV-1 virions for dissemination in trans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 buds predominantly at the plasma membrane of primary human macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Dendritic-cell interactions with HIV: infection and viral dissemination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 integration in the human genome favors active genes and local hotspots

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Transcriptional interference between convergent promoters caused by elongation over the promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Collision events between RNA polymerases in convergent transcription studied by atomic force microscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

RNA interference against retroviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Small interfering RNA-induced transcriptional gene silencing in human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Approaches for the sequence-specific knockdown of mRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Transcriptional interference antagonizes proviral gene expression to promote HIV latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

An ungracious host for an unwelcome guest

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Transcriptional interference: an unexpected layer of complexity in gene regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Translating the Histone Code

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Centrosomal pre-integration latency of HIV-1 in quiescent cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Duration of nuclear NF-kappaB action regulated by reversible acetylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

MLL histone methylases in gene expression, hormone signaling and cell cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Heterochromatin and epigenetic control of gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

T-cell-receptor- and B-cell-receptor-mediated activation of NF-kappaB in lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Primitive hematopoietic cells resist HIV-1 infection via p21

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

SIRT1 regulates HIV transcription via Tat deacetylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

COMMD proteins, a novel family of structural and functional homologs of MURR1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Interfering RNA and HIV: reciprocal interferences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Strategies for silencing human disease using RNA interference

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Keeping quiet: microRNAs in HIV-1 latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 nef suppression by virally encoded microRNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Regulation of human immunodeficiency virus 1 transcription by nef microRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 encoded candidate micro-RNAs and their cellular targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV may produce inhibitory microRNAs (miRNAs) that block production of CD28, CD4 and some interleukins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

CD28-dependent HIV-1 transcription is associated with Vav, Rac, and NF-kappa B activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Analysis of the interaction of primate retroviruses with the human RNA interference machinery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 Tat interaction with Dicer: requirement for RNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Suppression of microRNA-silencing pathway by HIV-1 during virus replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Changes in microRNA expression profiles in HIV-1-transfected human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Insights into cellular microRNAs and human immunodeficiency virus type 1 (HIV-1).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Raltegravir with optimized background therapy for resistant HIV-1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Thalidomide inhibits the replication of human immunodeficiency virus type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

In vitro selective elimination of HIV-infected cells from peripheral blood in AIDS patients by the immunotoxin DAB389CD4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Molecular Characterization, Reactivation, and Depletion of Latent HIV

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Stability of the latent reservoir for HIV-1 in patients receiving valproic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2223

Integration is essential for efficient gene expression of human immunodeficiency virus type 1.

31 March 2020

1 reference

12 December 2020

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

1 reference

12 December 2020

Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target

1 reference

12 December 2020

Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation

1 reference

12 December 2020

Follicular dendritic cells and the persistence of HIV infectivity: the role of antibodies and Fcgamma receptors

1 reference

12 December 2020

Pneumocystis pneumonia--Los Angeles

1 reference

12 December 2020

Purification by DNA affinity chromatography of two polypeptides that contact the NF-AT DNA binding site in the interleukin 2 promoter

1 reference

12 December 2020

Chemokines and their receptors in lymphocyte traffic and HIV infection

1 reference

12 December 2020

MicroRNAs in human immunodeficiency virus-1 infection.

1 reference

12 December 2020

Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools.

1 reference

12 December 2020

Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals

1 reference

12 December 2020

A novel mode of human immunodeficiency virus type 1 (HIV-1) activation: ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes

1 reference

12 December 2020

Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study

1 reference

12 December 2020

Transcription termination and polyadenylation in retroviruses

1 reference

12 December 2020

HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure

1 reference

12 December 2020

Nuclear export signal of IκBα interferes with the Rev-dependent posttranscriptional regulation of human immunodeficiency virus type I

1 reference

12 December 2020

Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO2223

1 reference

21 August 2017

1 reference